Navigation Links
Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update
Date:5/11/2009

- Conference Call Today at 4:30 p.m. Eastern Time -

SAN FRANCISCO, May 11 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today reported on its corporate progress and financial results for the first quarter ended March 31, 2009.

"We continue to make significant progress with both of our product candidates -- Dimebon in patients with Alzheimer's and Huntington's diseases and MDV3100 in patients with prostate cancer. Having received written permission from the FDA to initiate a pivotal Phase 3 trial of MDV3100 in castration-resistant prostate cancer, we are on track to be in Phase 3 testing in all of our clinical programs this year," said David Hung, M.D., president and chief executive officer of Medivation. "We expect to achieve a significant milestone in June - completion of enrollment in our six-month, confirmatory, pivotal Phase 3 CONNECTION trial in mild-to-moderate Alzheimer's disease. And as part of our plan to support a broad and differentiated label for Dimebon in Alzheimer's disease, we are pleased to have initiated the Phase 3 CONCERT trial of Dimebon in combination with donepezil (Aricept(R)), and intend to begin two additional Phase 3 trials in moderate-to-severe Alzheimer's disease patients this year."

Recent Highlights and Accomplishments

Dimebon

  • Expect to complete patient enrollment in CONNECTION, a confirmatory, pivotal Phase 3 trial in patients with mild-to-moderate Alzheimer's disease, in June.
  • Initiated the Phase 3 CONCERT trial in patients with mild-to-moderate Alzheimer's disease; the 12-month clinical trial is designed to evaluate the efficacy of Dimebon when added to ongoing treatment with donepezil (Aricept(R)), the leading Alzheimer's disease medication worldwide, and builds on
    '/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Medivation to Announce Early Positive Data from Phase 1-2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday, November 5, 2007
2. Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimers Disease in Second Quarter of 2008
3. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
4. Medivation Announces Participation in Upcoming Conferences
5. Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
6. Medivation Announces Participation in Upcoming Conferences
7. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
8. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
9. Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
10. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
11. Haemacure Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... -- Elementary school students seem to be satisfied with the ... new study of school officials. , , New meal standards ... into effect in the fall of 2012. At the time, ... throw away most of their food. But the new study ... case. , , "The updated meals standards are resulting in ...
(Date:7/28/2014)... TN (PRWEB) July 28, 2014 ... Operation Military June . Renowned LASIK and ... June" to provide significant funds and public awareness ... and retired military personnel and their families. “This ... will proudly give nearly $5,000 to a variety ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... are at risk of contracting meningitis because of specific ... to updated recommendations from the largest pediatrician group in ... the potentially deadly infection should continue for adolescents and ... In its first statement on meningococcal vaccines since 2011, ...
(Date:7/28/2014)... Reinberg HealthDay Reporter MONDAY, ... and heart rhythm irregularities are more likely to get a ... In fact, the study of more than 16,000 people found ... likely to get a pacemaker than those without the memory-robbing ... why folks with dementia are so much more likely to ...
(Date:7/28/2014)... Dearborn, Michigan (PRWEB) July 28, 2014 ... from Drs. Harris, Birkhill, Wang, Songe and Associates, PC ... generations and countless tomorrows to come. , The ... group, responsible for more than $2.5 million in donations. ... the title sponsors for the Oakwood Women’s Healthcare Classic ...
Breaking Medicine News(10 mins):Health News:Healthy School Lunches Get Thumbs Up From Students 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 3
... Postgraduate Services® (PPS®), renowned for its award-winning healthcare websites, ... and pediatric influenza, Preventing and Managing RSV Disease and ... PediatricRespiratory.org. , ... ...
... TodayMD to Deliver Comprehensive SEM Program to Medical and Dental ... ... September 9, 2009-- http://www.TodayMD.com [TodayMD], an innovator in ... announced today a strategic relationship with Google to become an ...
... Medical Solutions, Inc., a traveling healthcare staffing company, is ... 500 list of the fastest-growing private companies in the ... Solutions ranked No. 472 overall. When compared to other ... 4 and was No. 1 for all traveling healthcare ...
... over 60 million Americans diagnosed with prediabetes, putting them ... obesity-related ailments, finding ways to help large populations avoid ... published in the October 2008 issue of the ... Indiana University School of Medicine report that organizations such ...
... OF PRUSSIA, Pa., Sept. 8 Universal,Health Services, ... it has signed a,definitive agreement to sell Central ... located in Lansdale, Pennsylvania to Abington Memorial,Hospital. The ... we,expect the closing to occur later this fall., ...
... for ,08, ,09, ,10, Dey expected to ... Sept. 8 Following the completion,of a comprehensive review ... MYL ) branded specialty pharmaceutical subsidiary, Mylan,announced today that ... the company said it is reaffirming its adjusted diluted,EPS ...
Cached Medicine News:Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 2Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 3Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 4Health News:TodayMD Becomes a Google AdWords Authorized Reseller 2Health News:TodayMD Becomes a Google AdWords Authorized Reseller 3Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 2Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 3Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 4Health News:Community-based diabetes prevention program shows promise 2Health News:Universal Health Services, Inc. Announces Sale of Acute Care Hospital and Addition of Two Behavioral Health Hospitals 2Health News:Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary 2Health News:Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary 3Health News:Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary 4
(Date:7/28/2014)... July 28, 2014  Dignity Health St. Mary,s ... the Get With The Guidelines®-Stroke Silver-Plus Quality Achievement ... by the American Heart Association/American Stroke Association for ... number four cause of death and a leading ... United States , according to the American ...
(Date:7/28/2014)... , July 28, 2014 Reportbuyer.com has ... Global Bone Densitometers Market 2014-2018 ... bone densitometry scan is a special type of X-ray ... bone. It is used primarily to detect osteopenia or ... and the risk of fractures is high. The purpose ...
(Date:7/28/2014)... 28, 2014 Reportlinker.com announces that a ... catalogue: Portugal Pharmaceuticals and Healthcare ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html Includes 3 FREE ... economic growth last quarter has led us to ... As forecast previously, BMI expects Portugal,s ...
Breaking Medicine Technology:Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4
... PARK, Calif., Sept. 30 3-V Biosciences, Inc. announced ... as Chief Executive Officer.   (Logo:   ... "We are very pleased to have ... M. Mott, 3-V,s Executive Chairman, who is returning to ...
... Aethlon Medical, Inc. (OTC Bulletin Board: ... to address infectious disease and cancer, announced today that ... the establishment of federal partnerships that advance biodefense, cancer, ... The Aethlon Hemopurifier® is the first medical device to ...
Cached Medicine Technology:3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer 2Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 2Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 3Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 4Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 5
Indications For Usage: , ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hou...
... protection to the exposed airway of the tracheostomy ... it ideal for active young children as well ... and moisture recovery, it ensures patient comfort and ... have ISO standard tapered ends to assure a ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
Medicine Products: